The global hospital acquired urinary tract infection market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients with chronic kidney disease and diabetes mellitus, which are major risk factors for UTI. The increasing prevalence of these diseases in developing countries such as China and India is also driving the growth of this market.
The microbial testing instruments segment accounted for the largest share in 2018, followed by reagents and consumables segment. The infection prevention and surveillance software segment accounted for a small share in 2018 due to its high cost but it is expected to grow at a CAGR of 8% during the forecast period owing to its ability to provide real-time data on infections that can be used by healthcare providers for better management decisions.
Some Of The Growth Factors Of This Market:
- The number of hospital acquired urinary tract infections is increasing due to the aging population and the increase in chronic diseases.
- The number of hospital acquired urinary tract infections is increasing due to the increase in antibiotic resistant bacteria.
- The number of hospital acquired urinary tract infections is increasing due to the lack of hand washing by healthcare workers and patients, which can lead to cross-contamination between patients and their environment.
- The number of hospital acquired urinary tract infections is increasing due to a lack of infection control practices such as proper cleaning, disinfection, and sterilization procedures for medical equipment used on multiple patients without being cleaned or sterilized between uses; improper use or storage; inadequate ventilation; overcrowding; poor housekeeping practices that lead to accumulation of dust, dirt, food particles, animal dander, etc; inadequate staffing levels that lead to fatigue among staff members who are more likely not following infection control procedures properly because they are tired from working long hours with little break time; insufficient training for staff members on infection control procedures that leads them not following them properly because they don't know how or why they should be done correctly in order for them work effectively at preventing transmission from one patient's body fluids (urine) onto another patient's body fluids (urine).
- Hospital Acquired Urinary Tract Infections are becoming more common because there has been an increase in antibiotic resistant bacteria which makes it difficult for antibiotics prescribed by doctors to work effectively against these bacteria.
Industry Growth Insights published a new data on “Hospital Acquired Urinary Tract Infection Market”. The research report is titled “Hospital Acquired Urinary Tract Infection Market research by Types (Microbial Testing Instruments, Reagents and Consumables, Infection Prevention and Surveillance Software), By Applications (Disease Testing, Drug-resistance Testing), By Players/Companies Advanced Sterilization Products, Becton, Dickinson and Company, Steris Corporation, Getinge Group, Kimberly-Clark Corporation, Cantel Medical, Biomerieux, Belimed, 3M Company, Sterigenics International, Synergy Health, PLC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hospital Acquired Urinary Tract Infection Market Research Report
By Type
Microbial Testing Instruments, Reagents and Consumables, Infection Prevention and Surveillance Software
By Application
Disease Testing, Drug-resistance Testing
By Companies
Advanced Sterilization Products, Becton, Dickinson and Company, Steris Corporation, Getinge Group, Kimberly-Clark Corporation, Cantel Medical, Biomerieux, Belimed, 3M Company, Sterigenics International, Synergy Health, PLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Hospital Acquired Urinary Tract Infection Market Report Segments:
The global Hospital Acquired Urinary Tract Infection market is segmented on the basis of:
Types
Microbial Testing Instruments, Reagents and Consumables, Infection Prevention and Surveillance Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Disease Testing, Drug-resistance Testing
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advanced Sterilization Products
- Becton
- Dickinson and Company
- Steris Corporation
- Getinge Group
- Kimberly-Clark Corporation
- Cantel Medical
- Biomerieux
- Belimed
- 3M Company
- Sterigenics International
- Synergy Health
- PLC
Highlights of The Hospital Acquired Urinary Tract Infection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microbial Testing Instruments
- Reagents and Consumables
- Infection Prevention and Surveillance Software
- By Application:
- Disease Testing
- Drug-resistance Testing
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hospital Acquired Urinary Tract Infection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hospital acquired urinary tract infection (UTI) is an infection that can be caused by bacteria, viruses, or fungi. It most often occurs in people who have been hospitalized or are receiving medical care. UTIs can lead to serious health problems if not treated quickly.
Some of the key players operating in the hospital acquired urinary tract infection market are Advanced Sterilization Products, Becton, Dickinson and Company, Steris Corporation, Getinge Group, Kimberly-Clark Corporation, Cantel Medical, Biomerieux, Belimed, 3M Company, Sterigenics International, Synergy Health, PLC.
The hospital acquired urinary tract infection market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hospital Acquired Urinary Tract Infection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hospital Acquired Urinary Tract Infection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hospital Acquired Urinary Tract Infection Market - Supply Chain
4.5. Global Hospital Acquired Urinary Tract Infection Market Forecast
4.5.1. Hospital Acquired Urinary Tract Infection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hospital Acquired Urinary Tract Infection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hospital Acquired Urinary Tract Infection Market Absolute $ Opportunity
5. Global Hospital Acquired Urinary Tract Infection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
5.3.1. Microbial Testing Instruments
5.3.2. Reagents and Consumables
5.3.3. Infection Prevention and Surveillance Software
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hospital Acquired Urinary Tract Infection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
6.3.1. Disease Testing
6.3.2. Drug-resistance Testing
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hospital Acquired Urinary Tract Infection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hospital Acquired Urinary Tract Infection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hospital Acquired Urinary Tract Infection Demand Share Forecast, 2019-2026
9. North America Hospital Acquired Urinary Tract Infection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
9.4.1. Disease Testing
9.4.2. Drug-resistance Testing
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
9.7.1. Microbial Testing Instruments
9.7.2. Reagents and Consumables
9.7.3. Infection Prevention and Surveillance Software
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hospital Acquired Urinary Tract Infection Demand Share Forecast, 2019-2026
10. Latin America Hospital Acquired Urinary Tract Infection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
10.4.1. Disease Testing
10.4.2. Drug-resistance Testing
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
10.7.1. Microbial Testing Instruments
10.7.2. Reagents and Consumables
10.7.3. Infection Prevention and Surveillance Software
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hospital Acquired Urinary Tract Infection Demand Share Forecast, 2019-2026
11. Europe Hospital Acquired Urinary Tract Infection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
11.4.1. Disease Testing
11.4.2. Drug-resistance Testing
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
11.7.1. Microbial Testing Instruments
11.7.2. Reagents and Consumables
11.7.3. Infection Prevention and Surveillance Software
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hospital Acquired Urinary Tract Infection Demand Share, 2019-2026
12. Asia Pacific Hospital Acquired Urinary Tract Infection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
12.4.1. Disease Testing
12.4.2. Drug-resistance Testing
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
12.7.1. Microbial Testing Instruments
12.7.2. Reagents and Consumables
12.7.3. Infection Prevention and Surveillance Software
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hospital Acquired Urinary Tract Infection Demand Share, 2019-2026
13. Middle East & Africa Hospital Acquired Urinary Tract Infection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Application
13.4.1. Disease Testing
13.4.2. Drug-resistance Testing
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hospital Acquired Urinary Tract Infection Market Size and Volume Forecast by Type
13.7.1. Microbial Testing Instruments
13.7.2. Reagents and Consumables
13.7.3. Infection Prevention and Surveillance Software
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hospital Acquired Urinary Tract Infection Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hospital Acquired Urinary Tract Infection Market: Market Share Analysis
14.2. Hospital Acquired Urinary Tract Infection Distributors and Customers
14.3. Hospital Acquired Urinary Tract Infection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Advanced Sterilization Products
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Becton
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Dickinson and Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Steris Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Getinge Group
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kimberly-Clark Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cantel Medical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biomerieux
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Belimed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. 3M Company
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Sterigenics International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Synergy Health
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PLC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
